Medscape Medical News
June 12 2013
Jeni Laidman, reporter for Medscape Medical News, covered a long-term study that showed survival rates have increased significantly among patients who received blood stem cell transplants from both related and unrelated donors. Published in the Journal of Clinical Oncology, the study was conducted in collaboration with the Center for International Blood and Marrow Transplant Research (CIBMTR), the research arm of the National Marrow Donor Program (NMDP) and Be The Match. Navneet S. Majhail, MD, MS, medical director of the NMDP and Be The Match, noted that survival has increased, despite more high-risk procedures. The study authors attribute the increase in survival to several factors, including advances in HLA tissue typing, better supportive care and earlier referral for transplantation.